MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Revie

Show all filings for MEDICAL INTERNATIONAL TECHNOLOGY INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICAL INTERNATIONAL TECHNOLOGY INC 29-Oct-2009Non-Reliance on Previous Financials, Audits or Interim Revie Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All infor...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sal

Show all filings for MEDICAL INTERNATIONAL TECHNOLOGY INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICAL INTERNATIONAL TECHNOLOGY INC 24-Sep-2009Entry into a Material Definitive Agreement, Unregistered Sal Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Plan of Operations This quarterly report on Form 10-Q and other reports filed by Registrant from time to time with the Securities and Exchange Commission (collectively the "Filings") contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, Registrant's management as well as estimates and assumptions made by Registrant's management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the filings, the words "anticipate", "believe", "estimate", "expect", "future", "intend", "plan", or the negative of these terms and similar expressions as they relate to Registrant or Registrant's management identify forward-looking statements. Such statements reflect the current view of Registrant with respect to future events and are subject to risks, uncertainties, assumptions, and other factors (including the risks contained in the section of this report entitled "Risk Factors") relating to Registrant's industry, Registrant's operations and results of operations, and any businesses that Registrant may acquire. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Although Registrant believes that the expectations reflected in the forward-looking statements are reasonable, Registrant cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Registrant does not intend to update any of the forward-looking statements to conform these statements to actual r...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Plan of Operations All statements that are included in this Quarterly Report, other than statements of historical fact, are forward looking statements. Although management believes that the expectations reflected in these forward looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Financial Summary Results of Operations for the Six-Months ended March 31, 2009 and 2008 For the six-month period ended March 31, 2009, the Company experienced a net loss from operations of $1,093,083 which was primarily due to research and development costs of $900,000 and selling, general and administrative expenses of $266,239. Gross profits for the period were $73,156. For the six-month period ended March 31, 2008, the Company's net loss from operations was $450,981, which was primarily due to research and development costs of $181,053 and selling, general and administrative expenses of $336,101. Gross profits for this period were $66,176. For the six-months ended March 31, 2009, the Company experienced a decrease in sales compared to sales for the same period last year. Sales for the six-month period ending March 31, 2009 were $158,917 compared to sales of $165,507 for the same period last year. Gross profits for the period ending March 31, 2009 represented 46% of sales, where gross profits for the same period last year represented 40% of sales. Liquidity and Capital Resources For the six-month period ending March 31, 2009, the Company's cash position decreased $46,597. Net cash used in operating activities was $824,113; financing activities provided $681,602; and the effect of exchange rates on cash provided $95,914 For the six-month period ending March 31, 2008, the Company's cash position increased $261,419. Net cash used in operating activities was $734,739; financing activities provided $317,518; a...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sal

Show all filings for MEDICAL INTERNATIONAL TECHNOLOGY INC | Request a Trial to NEW EDGAR Online Pro Form 8-K for MEDICAL INTERNATIONAL TECHNOLOGY INC 28-Apr-2009Entry into a Material Definitive Agreement, Unregistered Sal Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 10-Q, Quarterly Report

Item 2. Management's Discussion and Analysis of Financial Condition and Plan of Operations All statements that are included in this Quarterly Report, other than statements of historical fact, are forward looking statements. Although management believes that the expectations reflected in these forward looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Financial Summary Results of Operations for the Three-Months ended December 31, 2008 and 2007 For the three-month period ended December 31, 2008, the Company experienced a net loss from operations of $577,073 which was primarily due to research and development costs of $450,000 and selling, general and administrative expenses of $146,378. Gross profits for the period were $19,305. For the three-month period ended December 31, 2007, the Company's net loss from operations was $159,930, which was primarily due to research and development costs of $55,064 and selling, general and administrative expenses of $172,059. Gross profits for this period were $67,193. For the three-months ended December 31, 2008, the Company experienced an increase in sales compared to sales for the same period last year. Sales for the three-month period ending December 31, 2008 were $70,915 compared to sales of $118,592 for the same period last year. Gross profits for the period ending December 31, 2008 represented 27% of sales, where gross profits for the same period last year represented 56% of sales. Liquidity and Capital Resources For the three-month period ending December 31, 2008, the Company's cash position decreased $83,130. Net cash used in operating activities was $438,218; financing activities provided $186,354; and the effect of exchange rates on cash provided $168,734 For the three-month period ending December 31, 2007, the Company's cash position decreased $169,085. Net cash used in operating activities was $994,152; finan...
Click here to read the whole Article (external link)

MEDICAL INTERNATIONAL TECHNOLOGY INC Files SEC form 10KSB, Annual Report

Item 6. Management's Discussion and Analysis or Plan of Operations When used in this Form 10-KSB and in future filings by the company with the Commission, statements identified by the words "believe", "positioned", "estimate", "project", "target", "continue", "will", "intend", "expect", "future", "anticipates", and similar expressions express management's present belief, expectations or intentions regarding the company's future performance within the meaning of the Private Securities Litigation Reform Act of 1995. The safe harbor in the Private Securities Litigation Act of 1995 does not apply to statements made in this document. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The company has no obligations to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements. Overview The following discussions and analysis should be read in conjunction with the Company's consolidated financial statements and the notes presented following the financial statements. The discussion of results, causes and trends should not be construed to imply any conclusion that such results or trends will necessarily continue in the future. Medical International Technology, Inc. (MIT) is receiving revenues from sales. The company has maintained operations from these revenues and through equity and debt financing. The company has been dependent on advances from related parties to maintain operations. There are no agreements, assurances or commitments to continue providing the...
Click here to read the whole Article (external link)